文献速递慢性肾脏病肾小球疾病

全基因组筛选揭示过氧化物酶体在APOL1足细胞病中的作用

Genome-wide screen identifies peroxisomal role in APOL1 podocytopathy.
PubMed 文献 · Kidney Int · 2026-06-17

该研究通过全基因组RNA干扰筛选发现,过氧化物酶体生物发生基因是APOL1 G1/G2风险变异体细胞毒性的修饰因子,在缺氧条件下沉默PEX基因显著加剧细胞死亡,而增强过氧化物酶体功能可减轻细胞毒性;机制上APOL1 C端存在功能性过氧化物酶体靶向信号,介导缺氧依赖的转运。

要点

  • 过氧化物酶体功能障碍是缺氧下APOL1 G1/G2介导足细胞损伤的重要决定因素。
  • 增强过氧化物酶体功能可减轻APOL1风险变异体诱导的细胞毒性。
  • APOL1 C端过氧化物酶体靶向信号介导缺氧依赖的过氧化物酶体转运。

核心结论

  • 过氧化物酶体功能障碍是缺氧应激下APOL1 G1/G2介导细胞毒性的重要决定因素,过氧化物酶体是限制足细胞损伤和CKD进展的可治疗通路。

研究设计与样本

  • 在表达APOL1 G1或G2的细胞中进行无偏倚全基因组RNA干扰筛选,以鉴定缺氧应激下修饰APOL1变异体诱导细胞毒性的通路。
  • 候选基因通过靶向遗传操作、药物干预以及亚细胞定位和结构功能分析进行验证。

主要发现

  • RNA干扰筛选鉴定出多个过氧化物酶体生物发生(PEX)基因作为APOL1 G1或G2细胞毒性的修饰因子。
  • 缺氧条件下沉默PEX基因显著加剧细胞死亡,提示过氧化物酶体稳态受损是APOL1相关细胞损伤的易感因素。
  • 遗传或药物增强过氧化物酶体功能可显著减轻任一APOL1风险变异体诱导的细胞毒性。
  • 鉴定出APOL1 C端功能性过氧化物酶体靶向信号,介导缺氧依赖的过氧化物酶体转运。
  • 破坏该靶向信号减少APOL1 G1/G2变异体的过氧化物酶体定位并减轻细胞毒性。

临床怎么用

  • 针对过氧化物酶体功能的药理学增强可能成为减缓遗传易感人群足细胞损伤和CKD进展的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Risk variants G1 and G2 of APOL1 confer a markedly increased risk of chronic kidney disease (CKD) in individuals of African ancestry, yet disease expression requires secondary insults such as inflammation or hypoxia. How these stressors intersect with APOL1 risk variants to drive podocyte injury and cell death remains poorly defined. METHODS: To identify pathways that modify APOL1 variant-induced cytotoxicity under hypoxic stress, we performed an unbiased, genome-wide RNA interference (RNAi) screen in cells expressing APOL1 G1 or G2. Candidate genes were validated using targeted genetic manipulation, pharmacologic interventions, and subcellular localization and structure-function analyses. RESULTS: The RNAi screen identified multiple peroxisomal biogenesis (PEX) genes as modifiers of APOL1 G1 or G2 cytotoxicity, with PEX gene silencing markedly exacerbating cell death during hypoxia. This implicates impaired peroxisomal homeostasis as a previously unappreciated vulnerability in APOL1-associated cellular injury. In contrast, genetic or pharmacologic enhancement of peroxisomal function significantly attenuated cytotoxicity induced by either APOL1 risk variant. Mechanistically, we identified a functional peroxisomal targeting signal at the C-terminus of APOL1 that mediates hypoxia-dependent trafficking to peroxisomes. Disruption of this targeting signal reduced peroxisomal localization of APOL1 G1/G2 variants and mitigated cytotoxicity, linking peroxisomal trafficking to variant-specific injury. CONCLUSIONS: Our findings identify peroxisomal dysfunction as an important determinant of APOL1 G1/G2-mediated cytotoxicity under hypoxic stress. By establishing a mechanistic connection between hypoxia, peroxisomal biology, and APOL1 risk variants, our work highlights peroxisomes as a therapeutically actionable pathway to limit podocyte injury and CKD progression in genetically susceptible population.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Kim J, Karel IZ, Song H, et al. Genome-wide screen identifies peroxisomal role in APOL1 podocytopathy. Kidney Int. 2026. PMID: 42309203. doi:10.1016/j.kint.2026.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。